Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Diffuse Large B-Cell Lymphoma Resource Center

Diffuse Large B-Cell Lymphoma
Learning Library

New & Trending

EZH2
Rapid Refresh
Understanding the Role of EZH2 in Cancer Pathogenesis
02/28/2024
This animation explains the role of EZH2 in the regulation of cell growth and the effects of EZH2 overexpression.
This animation explains the role of EZH2 in the regulation of cell growth and the effects of EZH2 overexpression.
This animation explains the role...
02/28/2024
APP Institute Oncology
Oluwatobi Odetola, MD,
Conference Coverage
Promising Efficacy of Frontline Nivolumab in Combination With R-CHOP for Patients With High-Risk DLBCL
12/12/2023
During the 2023 ASH Annual Meeting in San Diego, Oluwatobi Odetola, MD, shared data from a phase 1b study that evaluated the safety and efficacy of nivolumab in combination with R-CHOP in high-risk DLBCL.
During the 2023 ASH Annual Meeting in San Diego, Oluwatobi Odetola, MD, shared data from a phase 1b study that evaluated the safety and efficacy of nivolumab in combination with R-CHOP in high-risk DLBCL.
During the 2023 ASH Annual...
12/12/2023
Oncology
From Oncology
Narendranath Epperla, MD, MS
Conference Coverage
Analyzing Outcomes of Tafasitamab for the Treatment of R/R DLBCL Among Racial and Ethnic Minorities
12/11/2023
At the 2023 ASH Annual Meeting, Narendranath Epperla, MD, MS, presented a retrospective cohort study analyzing the patterns and outcomes of treatment with tafasitamab among patients with R/R diffuse large B-cell lymphoma across racial and...
At the 2023 ASH Annual Meeting, Narendranath Epperla, MD, MS, presented a retrospective cohort study analyzing the patterns and outcomes of treatment with tafasitamab among patients with R/R diffuse large B-cell lymphoma across racial and...
At the 2023 ASH Annual Meeting,...
12/11/2023
Oncology
From Oncology

Clinical Pearls

APP Perspectives

Lorinda Coombs
APP Perspectives
Myeloma Care: Patient and Advanced Practice Provider Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
APP Institute Oncology

Conference Coverage

Oluwatobi Odetola, MD,
Conference Coverage
Promising Efficacy of Frontline Nivolumab in Combination With R-CHOP for Patients With High-Risk DLBCL
12/12/2023
During the 2023 ASH Annual Meeting in San Diego, Oluwatobi Odetola, MD, shared data from a phase 1b study that evaluated the safety and efficacy of nivolumab in combination with R-CHOP in high-risk DLBCL.
During the 2023 ASH Annual Meeting in San Diego, Oluwatobi Odetola, MD, shared data from a phase 1b study that evaluated the safety and efficacy of nivolumab in combination with R-CHOP in high-risk DLBCL.
During the 2023 ASH Annual...
12/12/2023
Oncology
Narendranath Epperla, MD, MS
Conference Coverage
Analyzing Outcomes of Tafasitamab for the Treatment of R/R DLBCL Among Racial and Ethnic Minorities
12/11/2023
At the 2023 ASH Annual Meeting, Narendranath Epperla, MD, MS, presented a retrospective cohort study analyzing the patterns and outcomes of treatment with tafasitamab among patients with R/R diffuse large B-cell lymphoma across racial and...
At the 2023 ASH Annual Meeting, Narendranath Epperla, MD, MS, presented a retrospective cohort study analyzing the patterns and outcomes of treatment with tafasitamab among patients with R/R diffuse large B-cell lymphoma across racial and...
At the 2023 ASH Annual Meeting,...
12/11/2023
Oncology
Conference Coverage
New Patient Visits via Telehealth Improve Management of Patients With Monoclonal Gammopathy of Undetermined Significance at Increased Risk for Hematological Cancers
11/14/2024
Conducting new patient visits via telehealth with advanced practice providers allows for quicker identification, assessment, and surveillance of patients with monoclonal gammopathy of undetermined significance at increased risk of developing...
Conducting new patient visits via telehealth with advanced practice providers allows for quicker identification, assessment, and surveillance of patients with monoclonal gammopathy of undetermined significance at increased risk of developing...
Conducting new patient visits...
11/14/2024
APP Institute Oncology
Conference Coverage
Examining the Mental Health Needs of Patients With MDS and Their Caregivers
04/28/2024

Amber Denham

Amber Denham
Research highlights the importance of examining the mental health needs of caregivers of patients with myelodysplastic syndromes.
Research highlights the importance of examining the mental health needs of caregivers of patients with myelodysplastic syndromes.
Research highlights the...
04/28/2024
APP Institute Oncology
Conference Coverage
Mobile Health Application for Chronic GVHD Symptom Tracking in Patients Undergoing Allogeneic Transplant
04/27/2024

Janelle Bradley

Janelle Bradley
Study findings validate the feasibility and usability of a mobile health application for tracking symptoms of chronic GVHD among patients who received an allogeneic stem cell transplant.
Study findings validate the feasibility and usability of a mobile health application for tracking symptoms of chronic GVHD among patients who received an allogeneic stem cell transplant.
Study findings validate the...
04/27/2024
APP Institute Oncology
Conference Coverage
DASH Model Yields Improved Detection of Deterioration Among Patients Undergoing Hematopoietic Cell Transplantation
04/26/2024

Gina Tomaine

Gina Tomaine
The DASH machine learning model demonstrated superior benefits in identifying deterioration among patients undergoing HCT, which has great potential to improve patient outcomes, according to data presented at ONS Annual Congress.
The DASH machine learning model demonstrated superior benefits in identifying deterioration among patients undergoing HCT, which has great potential to improve patient outcomes, according to data presented at ONS Annual Congress.
The DASH machine learning model...
04/26/2024
APP Institute Oncology
Conference Coverage
Gut Microbial Composition, Diversity and Gastrointestinal Symptoms Among Patients With Breast Cancer
04/26/2024

Allison Casey

Allison Casey
According to a study presented at the 2024 ONS Annual Congress, multiple alterations in gut microbial composition and diversity were associated with GI symptoms and breast cancer status.
According to a study presented at the 2024 ONS Annual Congress, multiple alterations in gut microbial composition and diversity were associated with GI symptoms and breast cancer status.
According to a study presented...
04/26/2024
APP Institute Oncology
Conference Coverage
Exploring Benefits of Categorizing Symptom Clusters Among Younger vs Older Patients Undergoing Chemotherapy
04/26/2024

Amber Denham

Amber Denham
Routine assessment of the core symptoms associated with symptom clusters typical of older patients with cancer warrants consideration, as it may help to provide more targeted and effective symptom management for these patients.
Routine assessment of the core symptoms associated with symptom clusters typical of older patients with cancer warrants consideration, as it may help to provide more targeted and effective symptom management for these patients.
Routine assessment of the core...
04/26/2024
APP Institute Oncology
Conference Coverage
Objective Assessment Tool Enables Oncology Nurses to Escalate Treatment-Related Concerns to Physicians
04/25/2024

Stephanie Holland

Stephanie Holland
Use of the Non-Elective Solid Tumor (NEST) Treatment Verification Process enabled oncology nurses to efficiently escalate treatment-related concerns to physicians for patients set to undergo non-elective treatments, according to data...
Use of the Non-Elective Solid Tumor (NEST) Treatment Verification Process enabled oncology nurses to efficiently escalate treatment-related concerns to physicians for patients set to undergo non-elective treatments, according to data...
Use of the Non-Elective Solid...
04/25/2024
APP Institute Oncology
Conference Coverage
Standardized Screening Tool Demonstrates Benefits to Palliative Care for Oncologic ICU Patients
04/25/2024

Gina Tomaine

Gina Tomaine
The creation of a standardized screening tool successfully doubled rates of palliative care consult orders and helped identify palliative care needs that arose later in admission to the oncologic ICU.
The creation of a standardized screening tool successfully doubled rates of palliative care consult orders and helped identify palliative care needs that arose later in admission to the oncologic ICU.
The creation of a standardized...
04/25/2024
APP Institute Oncology
Conference Coverage
Researchers Develop Survey to Better Measure Oncology Nurses’ Professional Quality of Life
04/25/2024

Janelle Bradley

Janelle Bradley
Researchers developed a survey, the Oncology Nursing Professional Quality of Life survey, which aims to better measure oncology nurses’ professional quality of life.
Researchers developed a survey, the Oncology Nursing Professional Quality of Life survey, which aims to better measure oncology nurses’ professional quality of life.
Researchers developed a survey,...
04/25/2024
APP Institute Oncology
Conference Coverage
CASH Assessment Tool Shows Benefit of Holistic Communication for RN Navigators
04/25/2024

Allison Casey

Allison Casey
A pilot project found the CASH Assessment Tool was beneficial for holistic communication between RN Navigators and patients during an initial call.
A pilot project found the CASH Assessment Tool was beneficial for holistic communication between RN Navigators and patients during an initial call.
A pilot project found the CASH...
04/25/2024
APP Institute Oncology

Advertisement

Advertisement

APP Institute Oncology

 

The Advanced Practice Provider (APP) Institute is a new offering from the Oncology Learning Network that provides microburst education to oncology advanced practitioners. The platform offers year-round digital non-accredited learning modules through animated short videos, multimedia interviews with key opinion leaders, interactive content to test your knowledge, and more!

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement